MOSCOW (Sputnik) – Countries of the European Union could miss out on some new medicines for heart disease or cancer if the bloc keeps on promoting new legislation regulating the pharmaceutical industry, US media reported, citing David Ricks, the CEO of US pharmaceutical giant Eli Lilly.
Sputnik News
South Africa Today – World News – Latin America
